• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Guidelines for heart pacemaker therapy].

作者信息

Lemke B, Nowak B, Pfeiffer D

机构信息

Klinikum Lüdenscheid, Innere Klinik III, Kardiologie und Angiologie, Paulmannshöher Str. 14, 58515, Lüdenscheid.

出版信息

Z Kardiol. 2005 Oct;94(10):704-20. doi: 10.1007/s00392-005-0269-3.

DOI:10.1007/s00392-005-0269-3
PMID:16200488
Abstract
摘要

相似文献

1
[Guidelines for heart pacemaker therapy].[心脏起搏器治疗指南]
Z Kardiol. 2005 Oct;94(10):704-20. doi: 10.1007/s00392-005-0269-3.
2
[Statement of the Working Group of the Germany Society on the safety of asynchronous ventricular pacemaker stimulation ].[德国协会工作组关于异步心室起搏器刺激安全性的声明]
Clin Res Cardiol. 2006 Jan;95(1):57-60. doi: 10.1007/s00392-006-0309-7.
3
[Importance of the history and the utilization of therapy guidelines in patients with arrhythmias].[心律失常患者病史的重要性及治疗指南的应用]
Herzschrittmacherther Elektrophysiol. 2007 Mar;18(1):2-7. doi: 10.1007/s00399-007-0556-y.
4
Clinical practice patterns in implantable rhythm management device therapy: new players and new norms.
Pacing Clin Electrophysiol. 1999 May;22(5):814-5. doi: 10.1111/j.1540-8159.1999.tb00548.x.
5
Twofers and transaortic valve replacements.
JACC Cardiovasc Interv. 2015 May;8(6):847-849. doi: 10.1016/j.jcin.2015.03.009.
6
Optimal Implantation Depth and Adherence to Guidelines on Permanent Pacing to Improve the Results of Transcatheter Aortic Valve Replacement With the Medtronic CoreValve System: The CoreValve Prospective, International, Post-Market ADVANCE-II Study.优化植入深度并遵循永久性起搏指南以改善美敦力 CoreValve 系统经导管主动脉瓣置换术的结果：CoreValve 前瞻性、国际、上市后 ADVANCE-II 研究。
JACC Cardiovasc Interv. 2015 May;8(6):837-846. doi: 10.1016/j.jcin.2015.02.005.
7
Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey.在欧洲使用无导线起搏器：欧洲心律协会调查的结果。
Europace. 2018 Mar 1;20(3):555-559. doi: 10.1093/europace/eux381.
8
[Primary electrical heart diseases].
Herzschrittmacherther Elektrophysiol. 2005 Dec;16(4):225-8. doi: 10.1007/s00399-005-0489-2.
9
[Cardiac resynchronization therapy and arrhythmias].[心脏再同步治疗与心律失常]
Herzschrittmacherther Elektrophysiol. 2005 Mar;16(1):28-31. doi: 10.1007/s00399-005-0450-4.
10
[Guideline satisfying therapy for chronic heart failure].[慢性心力衰竭的指南导向性治疗]
Internist (Berl). 2007 Sep;48(9):929-37. doi: 10.1007/s00108-007-1898-6.

引用本文的文献

1
Influence of radiotherapy on cardiac implantable devices and leads-a single-institution analysis and critical evaluation of current guidelines.放射治疗对心脏植入式设备及导线的影响——单机构分析及对现行指南的批判性评估
Strahlenther Onkol. 2025 Apr;201(4):463-471. doi: 10.1007/s00066-024-02345-0. Epub 2025 Jan 10.
2
[History of cardiac resynchronization therapy : 30 years of electrotherapeutic management for heart failure].[心脏再同步治疗的历史：心力衰竭的30年电治疗管理]
Herzschrittmacherther Elektrophysiol. 2024 Mar;35(Suppl 1):68-76. doi: 10.1007/s00399-024-01004-2. Epub 2024 Feb 29.
3
Comparison of Safety of Leadless Pacemakers and Transvenous Pacemakers: A Meta-Analysis.

本文引用的文献

1
[Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].[晕厥诊断与治疗指南解读——欧洲心脏病学会2001年版及2004年更新版]
Z Kardiol. 2005 Sep;94(9):592-612. doi: 10.1007/s00392-005-0230-5.
2
The effect of cardiac resynchronization on morbidity and mortality in heart failure.心脏再同步化治疗对心力衰竭患者发病率和死亡率的影响。
N Engl J Med. 2005 Apr 14;352(15):1539-49. doi: 10.1056/NEJMoa050496. Epub 2005 Mar 7.
3
Guidelines on management (diagnosis and treatment) of syncope--update 2004.
无导线起搏器与经静脉起搏器安全性的比较：一项荟萃分析。
Cureus. 2023 Sep 12;15(9):e45086. doi: 10.7759/cureus.45086. eCollection 2023 Sep.
4
[Patients with implanted devices in intensive care medicine].[重症医学中植入式设备的患者]
Med Klin Intensivmed Notfmed. 2012 Jun;107(5):377-83. doi: 10.1007/s00063-012-0083-4. Epub 2012 May 4.
5
Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).慢性心房颤动对重度心力衰竭患者及心脏再同步化治疗指征的影响：来自两个登记处共711例患者（1999 - 2006年及2007 - 2008年6月）的数据
Herzschrittmacherther Elektrophysiol. 2011 Dec;22(4):226-32. doi: 10.1007/s00399-011-0155-9.
6
Current pacemaker and defibrillator therapy.当前的起搏器和除颤器治疗。
Dtsch Arztebl Int. 2011 May;108(21):372-9; quiz 380. doi: 10.3238/arztebl.2011.0372. Epub 2011 May 27.
7
[Heart failure update 2010 and current ESC guidelines].《2010年心力衰竭最新进展及欧洲心脏病学会现行指南》
Herz. 2010 Dec;35(8):535-40. doi: 10.1007/s00059-010-3396-1.
8
[The "Recommendations for the structure of cardiac pacemaker and defibrillator therapy"--what can they achieve?: Implementation of the concept paper for HSM/ICD therapy].["心脏起搏器和除颤器治疗结构的建议"——它们能实现什么？：心脏再同步化治疗/植入式心脏复律除颤器治疗概念文件的实施]
Herzschrittmacherther Elektrophysiol. 2010 Sep;21(3):166-73. doi: 10.1007/s00399-010-0099-5.
9
[Electrophysiologic diagnosis and therapy].[电生理诊断与治疗]
Med Klin (Munich). 2010 Jun;105(6):416-30. doi: 10.1007/s00063-010-1078-7.
10
[Life-threatening brady- and tachyarrhythmias].[危及生命的缓慢性和快速性心律失常]
Internist (Berl). 2010 Aug;51(8):975-6, 978-80, 982-6. doi: 10.1007/s00108-009-2539-z.
晕厥管理（诊断与治疗）指南——2004年更新版
Europace. 2004 Nov;6(6):467-537. doi: 10.1016/j.eupc.2004.08.008.
4
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.晚期慢性心力衰竭患者接受或不接受植入式除颤器的心脏再同步治疗。
N Engl J Med. 2004 May 20;350(21):2140-50. doi: 10.1056/NEJMoa032423.
5
Canadian Trial of Physiological Pacing: Effects of physiological pacing during long-term follow-up.加拿大生理性起搏试验：长期随访期间生理性起搏的效果。
Circulation. 2004 Jan 27;109(3):357-62. doi: 10.1161/01.CIR.0000109490.72104.EE. Epub 2004 Jan 5.
6
Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay.根据心室传导延迟严重程度分层的心力衰竭患者中使用左心室起搏的心脏再同步治疗的临床疗效。
J Am Coll Cardiol. 2003 Dec 17;42(12):2109-16. doi: 10.1016/j.jacc.2003.04.003.
7
Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.心脏再同步治疗用于治疗存在室内传导延迟和恶性室性心律失常的心力衰竭患者。
J Am Coll Cardiol. 2003 Oct 15;42(8):1454-9. doi: 10.1016/s0735-1097(03)01042-8.
8
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.在一项针对窦房结功能障碍的起搏器治疗临床试验中，心室起搏对基线QRS时限正常患者的心力衰竭和心房颤动的不良影响。
Circulation. 2003 Jun 17;107(23):2932-7. doi: 10.1161/01.CIR.0000072769.17295.B1. Epub 2003 Jun 2.
9
[Policy paper to the cardiac re-sychronization therapy].[关于心脏再同步治疗的政策文件]
Z Kardiol. 2003 Jan;92(1):96-103. doi: 10.1007/s00392-003-0906-7.
10
[Comment on NASPE recommendations for removal of permanently implanted, transvenous cardiac pacemaker and defibrillator electrodes].
Z Kardiol. 2002 Nov;91(11):956-68. doi: 10.1007/s00392-002-0891-2.